Navigation Links
Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
Date:10/20/2009

ARDEE, Ireland, Oct. 20 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activities.

"Dr. Fawzi is joining Warner Chilcott during a very exciting period in the company's history," said Roger Boissonneault, Warner Chilcott's President and Chief Executive Officer. "We look forward to the contributions he will make based on his experience and numerous achievements along the spectrum of R&D activities, from pre-development to life cycle management and commercial phases of drug development."

Prior to joining Warner Chilcott, Dr. Fawzi spent nearly 15 years with Wyeth, most recently as Executive Vice President, Preclinical Development where he led the development and launch of numerous new drugs. During his tenure, he was selected as one of four finalists for the Pharmaceutical Executive of the Year award. Prior to Wyeth, Dr. Fawzi also held positions with Warner Lambert, The Procter & Gamble Company and Pfizer, Inc.

Dr. Fawzi received his Bachelor of Science in Pharmacy from the University of Bagdad and his Masters and Doctorate in Pharmaceutical Chemistry from the University of Michigan.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

SOURCE Warner Chilcott plc


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
2. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
3. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
4. UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
5. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
6. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
7. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
8. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
9. Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels
10. Vincent W. Renz Joins NewCardio as President
11. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Research and Markets has announced the addition ... Demand Forecast to 2022" report to their offering. ... , , The ... and it is expected to grow at a CAGR of 5.5% during ... faster growth during the forecast period, a CAGR of 8.8% in the ...
(Date:12/2/2016)... , Dec. 2, 2016 Quantum Radiology,s Mobile ... expert radiologist interpretation directly to women at the workplace, ... corporations, such as Delta Air Lines and SunTrust Bank, ... as a component of wellness initiatives. "I ... SunTrust. It enables them to have a mammogram without ...
(Date:12/2/2016)... 2016 In the first ever attempt to ... derived from C. sativa, the Hebrew University in Jerusalem, ... Federico II , the Universita` del Piemonte Orientale and ... integrated and unified inventory of phytocannabinoids of different botanical ... the remarkable chemical and structural diversity of phytocannabinoids. As ...
Breaking Medicine Technology:
(Date:12/2/2016)... CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, Doctors ... basis to help personal injury victims find high quality medical care. When the company ... Angeles area. Fast forward to present day and the now ten-page directory features a ...
(Date:12/2/2016)... ... 02, 2016 , ... Center for Autism and Related Disorders (CARD) Portland today ... spectrum disorder (ASD) and other developmental disabilities. The group, which is being launched with ... caregivers the opportunity to share stories and advice, seek help, and continue their education ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of two ostomy patients, standing as living proof that attitude and determination can ... diseases and issues that spike around the holidays. This campaign will offer patients ...
(Date:12/2/2016)... Wilmington, Delaware (PRWEB) , ... December 02, 2016 ... ... has released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite ... from sample entry through labeling, storing, shipping and disposal. The new version is ...
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that ... technology on the market can deliver all that rejiva can. , “Rejiva promotes relaxation ... health than the usual heart rate and steps taken”, adds Evens Augustin, CEO of ...
Breaking Medicine News(10 mins):